Explore more publications!

Press Releases

ABSI Visits Washington, D.C. to Advocate for Autism Treatment and Family Support, Including Military Families
Pharma ADMET Testing Market 2026: Discover Drug Development Tools Accelerating Regulatory Success
Whitehouse Files Comment on Department of Energy’s Ill-Conceived “Categorical Exclusion” that Threatens to Undercut Nuclear Progress

Whitehouse Files Comment on Department of Energy’s Ill-Conceived “Categorical Exclusion” that Threatens to Undercut Nuclear Progress

Ultragenyx Pharmaceutical Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action - RGRD Law
NDSS Partners with CoorDown to Present the International Awareness Campaign “JUST EVOLVE”
DC Talk Therapy Responds to Growing OCD Demand in Washington, D.C.
Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
MONDAY DEADLINE: Ardent Health, Inc. Investors with Significant Losses Have Opportunity to Lead Class Action - RGRD Law
Tonix Pharmaceuticals Announces Publication of Clinical Pharmacokinetic Studies of TONMYA™ and Prototype Formulations in the Journal Clinical Pharmacology in Drug Development
Joseph Cammarata Named to Virginia Lawyers Weekly Hall of Fame
aTyr Pharma Announces Fourth Quarter and Full Year 2025 Results and Provides Corporate Update
The Relentless Pace of State PFAS Actions Discussed on B&C’s All Things Chemical® Podcast
B&C to Present Lexology Masterclass 'PFAS in consumer products: a multi-state compliance guide'
Trump Declares Emergency in D.C. Amid Potomac Sewage Crisis

Trump Declares Emergency in D.C. Amid Potomac Sewage Crisis

8.99% Annual Growth Forecasted for the Europe Dietary Supplements Market Driven by Plant-Based Nutrition | IMARC Group
Quantum Leap Energy Appoints Nate Salpeter, Ph.D., a Key Opinion Leader in Fluid Dynamics and Energy Technology, as its Chief Technology Officer
Eledon Pharmaceuticals to Participate in Leerink Partners 2026 Global Healthcare Conference
Lehigh County Launches 24/7 Public Health Kiosks to Expand Overdose Prevention Access
The New England Journal of Medicine Publishes First Data to Demonstrate the Potential for Disease Modification in Dravet Syndrome
Biomea Fusion Presents Phase II COVALENT-111 Data in Type 2 Diabetes at the 19th International Conference on Advanced Technologies & Treatments for Diabetes 2026

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions